首页> 美国卫生研究院文献>Frontiers in Immunology >Challenges in HIV Vaccine Research for Treatment and Prevention
【2h】

Challenges in HIV Vaccine Research for Treatment and Prevention

机译:HIV疫苗治疗和预防研究的挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many attempts have been made or are ongoing for HIV prevention and HIV cure. Many successes are in the list, particularly for HIV drugs, recently proposed also for prevention. However, no eradication of infection has been achieved so far with any drug. Further, a residual immune dysregulation associated to chronic immune activation and incomplete restoration of B and T cell subsets, together with HIV DNA persistence in reservoirs, are still unmet needs of the highly active antiretroviral therapy, causing novel “non-AIDS related” diseases that account for a higher risk of death even in virologically suppressed patients. These “ART unmet needs” represent a problem, which is expected to increase by ART roll out. Further, in countries such as South Africa, where six millions of individuals are infected, ART appears unable to contain the epidemics. Regretfully, all the attempts at developing a preventative vaccine have been largely disappointing. However, recent therapeutic immunization strategies have opened new avenues for HIV treatment, which might be exploitable also for preventative vaccine approaches. For example, immunization strategies aimed at targeting key viral products responsible of virus transmission, activation, and maintenance of virus reservoirs may intensify drug efficacy and lead to a functional cure providing new perspectives also for prevention and future virus eradication strategies. However, this approach imposes new challenges to the scientific community, vaccine developers, and regulatory bodies, such as the identification of novel immunological and virological biomarkers to assess efficacy end-points, taking advantage from the natural history of infection and exploiting lessons from former trials. This review will focus first on recent advancement of therapeutic strategies, then on the progresses made in preventative approaches, discussing concepts, and problems for the way ahead for the development of vaccines for HIV treatment and prevention.
机译:在预防艾滋病毒和治疗艾滋病毒方面已经进行或正在进行许多尝试。清单中列出了许多成功,特别是针对艾滋病毒的药物,最近也提出了预防措施。但是,到目前为止,任何药物都无法根除感染。此外,与慢性免疫激活和B和T细胞亚群的不完全恢复相关的残留免疫失调以及储库中的HIV DNA持久性仍然是高活性抗逆转录病毒疗法未满足的需求,导致了新型的“非艾滋病相关”疾病即使在病毒学抑制的患者中也造成较高的死亡风险。这些“ ART未满足的需求”代表了一个问题,随着ART的推出,这一问题有望增加。此外,在诸如南非这样的六百万人被感染的国家中,抗逆转录病毒疗法似乎无法控制这种流行病。遗憾的是,开发预防性疫苗的所有尝试都令人大失所望。但是,最近的治疗性免疫策略为HIV治疗开辟了新途径,也可用于预防性疫苗方法。例如,旨在针对负责病毒传播,激活和维持病毒库的关键病毒产品的免疫策略可能会增强药物功效并导致功能性治愈,这也为预防和未来的病毒消除策略提供了新的见解。但是,这种方法给科学界,疫苗开发人员和监管机构带来了新的挑战,例如,利用感染的自然历史并利用以前试验的经验,鉴定新的免疫学和病毒学生物标记物以评估功效终点。 。这篇综述将首先关注治疗策略的最新进展,然后关注预防方法的进展,讨论概念以及用于开发用于HIV治疗和预防的疫苗的未来道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号